La vendita allo scoperto per Akanda dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Akanda. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Akanda (NASDAQ:AKAN) Azioni, Report sulle vendite allo scoperto

Akanda

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.

Akanda Corp

In the current session, the stock is trading at $3.81, after a 3.81% increase. Over the past month, LexinFintech Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LX#NASDAQ">LX</a>) stock increased by 14.15%, and in the past year, by 80.20%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1730824264_0.png" alt="Past Year Chart" />

<h3>LexinFintech Holdings P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 24.2 in the Consumer Finance industry, LexinFintech Holdings Inc. has a lower P/E ratio of 5.3. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1730824264_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

News

Intraday Update

Markets

A Look Into LexinFintech Holdings Inc's Price Over Earnings

Piper Sandler analyst Thomas Champion reiterates Vimeo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) with a Neutral and raises the price target from $5 to $7.

Price Target

Reiteration

Analyst Ratings

VMEO

Piper Sandler Reiterates Neutral on Vimeo, Raises Price Target to $7

NRG Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) has outperformed the market over the past 5 years by 5.24% on an annualized basis producing an average annual return of 18.49%. Currently, NRG Energy has a market capitalization of $17.75 billion. 
Buying $100 In NRG: If an investor had bought $100 of NRG stock 5 years ago, it would be worth $234.21 today based on a price of $86.00 for NRG at the time of writing.
<h3>NRG Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730824226_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today

Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) has outperformed the market over the past 5 years by 16.86% on an annualized basis producing an average annual return of 30.12%. Currently, Datadog has a market capitalization of $42.19 billion. 
Buying $1000 In DDOG: If an investor had bought $1000 of DDOG stock 5 years ago, it would be worth $3,814.23 today based on a price of $125.14 for DDOG at the time of writing.
<h3>Datadog's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730824221_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DDOG

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,800 Today

WIIM

Clearwater Paper shares are trading higher. RBC Capital reiterated an Outperform rating on the stock.

ICHR

Ichor Holdings shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 revenue guidance above estimates. Also. B. Riley Securities raised its price target on the stock from $36 to $38.

INGR

Ingredion shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results and raised its FY24 adjusted EPS guidance above estimates.

Piper Sandler analyst Adam Maeder reiterates Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) with a Overweight and raises the price target from $255 to $260.

INSP

Piper Sandler Reiterates Overweight on Inspire Medical Systems, Raises Price Target to $260

RBC Capital analyst Conor McNamara maintains Hologic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>) with a Sector Perform and raises the price target from $86 to $89.

HOLX

RBC Capital Maintains Sector Perform on Hologic, Raises Price Target to $89

AOSL

Alpha & Omega shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS results. B. Riley Securities lowered its price target on the stock from $50 to $47.

Mark Cuban is an outspoken billionaire and part-owner of the Dallas Mavericks but also one of the most vocal critics of the former president. He has used terms like &#8220;fascist&#8221; to describe Trump&#8217;s behavior. However, Cuban was recently seen on ABC justifying his business relationship with Miriam Adelson, who gave Trump an astounding $100 million to support his 2024 election campaign.
Don't Miss:
<ul>
<li>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai">Be an early investor with just $1,000 for only $0.50/share today.</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
Adelson&#8217;s hefty donation to Trump – the largest of any sports team owner – shows she's all-in on Trump's campaign. That has made things somewhat awkward for Cuban, considering his loud and clear support for Kamala Harris, who is running against Trump.
Yet, when asked how he felt about this partnership, Cuban brushed off the issue. &#8220;Do you know how everyone is voting who you work with? Do you know how the owners of your company are voting? This is America. People get to choose their candidates and vote for who they want, which makes it amazing,&#8221; Cuban said in an interview. Cuban&#8217;s message is that differing political views shouldn't interfere with running a business.
See Also: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a>
Cuban also pointed out that he's not giving money to Harris – or any other political candidate, for that matter. Despite his <a href="https://www.benzinga.com/news/24/09/40745014/kamala-harris-is-pro-business-mark-cuban-says-vice-presidents-centre-100-policies-differ-from-bidens">vocal support for the current vice president</a>, Cuban hasn&#8217;t donated a penny to her campaign. He believes in making a difference through his words and influence instead of writing checks.
He's been on social media defending Harris and has engaged in fiery debates, <a href="https://www.benzinga.com/markets/equities/24/10/41568486/mark-cuban-highlights-trumps-potential-to-ruin-christmas-but-he-might-also-end-up-spoiling-the-p">calling out Trump's behavior</a> as dangerous and out of touch. Cuban also stated in the same ABC interview that &#8220;Donald Trump is not a normal candidate,&#8221; claiming that he has used divisive language and taken actions that, in Cuban&#8217;s opinion, verge on authoritarianism.
Trending: If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?
Despite clashing ideologies, Cuban seems comfortable keeping his business relationships and political beliefs separate. Miriam Adelson, who inherited a vast fortune from her late husband Sheldon Adelson, now <a href="https://www.benzinga.com/news/23/12/36231225/mark-cuban-to-retain-25-stake-in-dallas-mavericks-after-sale-to-adelson-family-report">shares ownership of the Mavericks with Cuban</a>. The Adelson family is deeply involved in politics and their support of Trump hasn't wavered. On the other hand, Cuban is sticking to his guns – supporting Harris in the media and making the case for what he believes is best for the country.
At the end of the day, Cuban seems determined to stay true to his political convictions and his business partnerships. &#8220;This is America,&#8221; he says – a place where people can disagree, even sharply and still find ways to work together.
Read Next:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
</ul>

Startups

'This Is America,' Mark Cuban Says, Justifying His Business Relationship With Trump's $100M Megadonor And Mavericks Co-Owner

<a href="https://www.benzinga.com/personal-finance/24/09/40714364/survive-anything-kevin-oleary-claims-you-need-5-million-in-savings-heres-how-you-can-reach-that-">Kevin O'Leary</a>, best known from Shark Tank, has backed Elon Musk's sweeping $2 trillion plan to slash federal spending. With former President Donald Trump's backing, Musk is proposed to head the Department of Government Efficiency (DOGE) if Trump secures a second term.&nbsp;
Don't Miss:
<ul>
<li>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai">Be an early investor with just $1,000 for only $0.50/share today.</a></li>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
</ul>
O'Leary enthusiastically remarked on Fox News, "Release the hounds" about unleashing Musk's cost-cutting skills across federal agencies. "Let them in there and come back with a shopping list of ideas and let's debate it. Why not? We need to find some savings."
In O'Leary's view, the U.S. federal government is "the biggest business in America." He sees Musk, the mind behind Tesla and SpaceX, as uniquely equipped to tackle this budget behemoth.&nbsp;
"Who has the executional skills and the track record to even look at this problem?" he said, emphasizing that Musk's focus and determination make him an ideal candidate. Indeed, O'Leary believes that Musk's efficiency ethos, which has driven companies like SpaceX to success, would transfer seamlessly to federal budget cuts – an area few entrepreneurs would tread.
Trending: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
Musk has clarified that he views today's government spending as unsustainable, especially with national debt interest payments now outstripping the defense budget.&nbsp;
Speaking at a Trump rally, he linked federal spending to inflation and increased taxes, which he warned are squeezing <a href="https://www.benzinga.com/personal-finance/24/08/40582239/californias-new-plan-taxpayers-might-soon-be-funding-home-loans-for-illegal-migrants-heres-what-">taxpayers </a>dry. With his proposal to shave off $2 trillion, Musk aims to start the work he sees as vital for long-term economic stability.
But this grand vision has detractors. Some experts question whether cutting a third of federal spending is possible without compromising essential services.&nbsp;
Analysis from the Washington Post noted that Musk&#8217;s cuts could gut programs like health care, food security and housing, impacting millions of Americans. Even previously untouchable sectors, such as Social Security and the military, may be affected.&nbsp;
See Also: Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence.&nbsp;</a>
Musk acknowledged on X (formerly Twitter) that his proposed cuts could result in economic turmoil, suggesting that hard times would be ahead before any benefits emerged.
Still, O'Leary remains undeterred. He sees Musk's focus as an asset, contrasting the entrepreneur's "100% signal" approach with what he describes as other business leaders' focus on "noise." To O'Leary, Musk's dedication to his projects means he is all about the mission and not distracted by side issues, making him ideal for leading such a challenging initiative.&nbsp;
He even suggested that Musk go beyond the $2 trillion target. "We've got to go find $2 trillion; we've got to go find $5 trillion," O'Leary urged.
Read Next:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a></li>
</ul>

Kevin O'Leary Supports Elon Musk's $2 Trillion Plan To Slash Government Spending With Trump's Backing–'It's Time To Release The Hounds'

COGT

Cogent Biosciences shares are trading lower after the company announced Bezuclantinib presentations at the 66th annual American Society of Hematology meeting.

RBC Capital analyst Sean Dodge reiterates IQVIA Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) with a Outperform and maintains $270 price target.

RBC Capital Reiterates Outperform on IQVIA Hldgs, Maintains $270 Price Target

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Outperform and raises the price target from $352 to $359.

Keefe, Bruyette & Woods Maintains Outperform on Willis Towers Watson, Raises Price Target to $359

PRAA

PRA Group shares are trading higher after the company reported better-than-expected Q3 financial results. Additionally, Truist Securities maintained a Buy rating on the stock and raised its price target from $28 to $31.

Keefe, Bruyette &amp; Woods analyst Thomas McJoynt-Griffith reiterates Root (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) with a Outperform and raises the price target from $82 to $90.

ROOT

Keefe, Bruyette & Woods Reiterates Outperform on Root, Raises Price Target to $90

CENX

Century Aluminum shares are trading higher after the company reported better-than-expected Q3 financial results and B.Riley Securities raised its price target on the stock from $22 to $24.

JP Morgan analyst Jessica Fye maintains Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Overweight and lowers the price target from $510 to $503.

VRTX

JP Morgan Maintains Overweight on Vertex Pharmaceuticals, Lowers Price Target to $503

Diversified Healthcare Trust shares are trading lower after the company reported worse-than-expected Q3 financial results.

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
One of the many advantages of <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a> is that you can easily create a customized portfolio. diversified across various sectors, geographies, and business types, allowing for the creation of a tailored portfolio that aligns closely with individual investment goals. Another advantage, of course, is that select companies can turn into 10X penny stocks overnight. And, sometimes, those 10X penny stocks break free from their micro-cap status to anchor long-term buy-and-hold portfolios. Even if not, 10X penny stocks can offer rapid rewards to traders looking for a short-term profit.



Penny stocks are rebounding this year as benchmarked ETFs like the iShares Micro-Cap ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/iwc-stock-quote/">IWC</a>) return just below 2%, even if it lags the overall market&rsquo;s 11% year-to-date return. However, this trend might be shifting as potential rate cuts, and the elimination of weaker penny stocks from the market may now position the surviving micro-caps as leading contenders in their category. Though penny stocks probably shouldn&rsquo;t be the bulk of your portfolio, strategically selecting for potential 10X penny stocks is a great way to learn underlying fundamentals through practical applications and research.



<h2>Nano Nuclear Energy (NNE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/06/shutterstock_1007906431-300x169.jpg" alt="clean energy stocks: a nuclear power plant in Belgium"><div>Source: engel.ac / Shutterstock</div></div>10X penny stock Nano Nuclear Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/nne-stock-quote/">NNE</a>) has had a wild ride since its public listing on May 13th; shares surged more than 100% at the end of the month before settling around $7.50 per share. That&rsquo;s nearly double the company&rsquo;s $4 IPO pricing, indicating big things ahead for the 10X penny stock, particularly considering its pre-revenue status.



As the name implies, the company is developing shipping-crate-sized nuclear reactors to mitigate power and electricity in some areas while offering &ldquo;surge&rdquo; assistance in areas needing tons of power quickly. Some of the tech&rsquo;s commercial application includes crypto mining, data center support, and artificial intelligence &mdash; and, of course, municipal governments may be interested in Nano Nuclear to support post-disaster management (like we&rsquo;re currently seeing in Texas). The federal government and defense industry likewise have plenty of use for small, compact, and (relatively) cheap portable energy sources.



Nano Nuclear&rsquo;s management thinks that their developing products could be fully deployable <a href="https://www.zerohedge.com/energy/nano-nuclear-thinks-it-will-be-first-company-sell-microreactors-2030-target">by 2030</a>, though that represents a problem for investors looking at 10X penny stocks &mdash; with minimal revenue projected between now and then, holding the stock for several years could be a lesson in opportunity cost. At the same time, though, there&rsquo;s clear enthusiasm surrounding the stock as we saw last week. In my mind, the company&rsquo;s current per-share pricing is a bit steep considering the risks, but I&rsquo;d look for a buying opportunity around the $6 mark.



<h2>The Metals Company (TMC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1771500521-300x169.png" alt="nickel stocks: a piece of nickel ore in front of a white background"><div>Source: aura23 / Shutterstock</div></div>I covered 10X penny stock The Metals Company (NASDAQ:<a href="https://investorplace.com/stock-quotes/tmc-stock-quote/">TMC</a>) in late April, <a href="https://investorplace.com/2024/04/from-cryptocurrency-to-cannabis-7-penny-stocks-on-the-rise/">specifically looking at</a> the company&rsquo;s inclusion of Steve Jurvetson of SpaceX and Tesla (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>) fame to their governance roster. I also noted that the company&rsquo;s current burn rate was concerning, as deep-sea metals mining (the company&rsquo;s focus) is pricy and demands high capital expenditures with limited opportunity for revenue until turning sea exploration into mining operations.



But that may soon change.



At the end of May, the company announced the sector&rsquo;s first successful battery-grade nickel mining operation. Tested by independent third-party scientists, the Pacific Ocean-sourced raw material can be turned into nickel sulphate, a major battery component. As of today, company management projects that their oceanic stake may hold enough nickel and other metals to meet the production needs for as many as 280 million electric vehicles (that&rsquo;s as many currently driving on US roadways).



Analysts expect that the company will soon reach <a href="https://finance.yahoo.com/news/analysts-expect-breakeven-tmc-metals-150754111.html">break-even status</a> and finally hit a path to profitability next year or by 2026. While that&rsquo;s a bit far out, it&rsquo;s a nearer-term 10X penny stock than Nano Nuclear &mdash; and much cheaper to boot.



<h2>Akanda (AKAN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/04/cannabis-stocks1600-3-300x169.png" alt="scientist checking organic hemp wild plants in a cannabis weed commercial greenhouse. Concept of herbal alternative medicine, cbd oil, pharmaceutical industry. Cannabis stocks, FLGC stocks"><div>Source: Chokniti-Studio / Shutterstock.com</div></div>Akanda (NASDAQ:<a href="https://investorplace.com/stock-quotes/akan-stock-quote/">AKAN</a>) stock soared in mid-May, nearly doubling on the heels of an announced and executed 1-for-40 reverse stock split. While reverse splits tend to be bearish indicators of a long-term lack of sustainability, in the case of 10X penny stocks, they&rsquo;re somewhat par for the course. Moreover, the company&rsquo;s slim shares outstanding stat, which sits at just 1.92 million, means that Akanda&rsquo;s stock volatility will likely continue as relatively few traders can move massive share quantities. This volatility, of course, is a recipe for 10X penny stock success, as smart traders can make money both ways by properly placing long or short bets.



On a longer horizon, I wouldn&rsquo;t call Akanda a solid buy-and-hold penny stock like Nano Nuclear or The Metals Company; while the latter two have a technical moat and are one of just a few penny stocks operating within their respective industries, Akanda&rsquo;s a small player in a large and rapidly growing cannabis sector. In the long run, Akanda&rsquo;s best bet is to seek acquisition or merger with a larger cannabis player &mdash; but that doesn&rsquo;t mean the 10X penny stock isn&rsquo;t worth actively trading amid all this volatility.



On Penny Stocks and Low-Volume Stocks:&nbsp;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/">Penny Stocks &mdash; How to Profit Without Getting Scammed</a>



On the date of publication, Jeremy Flint held no positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the <a href="http://InvestorPlace.com">InvestorPlace.com</a> <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
<div>Jeremy Flint, an MBA graduate and skilled finance writer, excels in content strategy for wealth managers and investment funds. Passionate about simplifying complex market concepts, he focuses on fixed-income investing, alternative investments, economic analysis, and the oil, gas, and utilities sectors. Jeremy&rsquo;s work can also be found at <a href="https://jeremyflint.work/">www.jeremyflint.work</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/06/penny-stocks-that-pack-a-punch-3-names-to-ride-for-10x-gains/">Penny Stocks That Pack a Punch: 3 Names to Ride for 10X Gains</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Penny Stocks That Pack a Punch: 3 Names to Ride for 10X Gains

Akanda Corp (AKAN) has released an update. Akanda Corp, an international medical cannabis company, has successfully regained compliance with Nasdaq...

Akanda Corp Back in Line with Nasdaq Standards

Akanda Corp (AKAN) has released an update. Akanda Corp, an international medical cannabis company, has fully utilized its $5 million Form F-3 shelf...

Akanda Corp Fully Capitalizes on Shelf Registration

Akanda Corp (AKAN) has released an update. Akanda Corp. has addressed its previous non-compliance with Nasdaq's minimum shareholders' equity requir...

Akanda Corp Regains Nasdaq Compliance

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start off the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday morning!



Moving stocks this morning are earnings reports, a failed merger deal, delisting updates and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>VSee Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsee-stock-quote/">VSEE</a>) stock is rocketing more than 159% as the robot maker <a href="https://www.nasdaq.com/press-release/vsee-health-and-ava-robotics-partner-develop-telepresence-solutions-hospital">plans for telepresence solutions</a> for the inpatient intensive care market.</li>



<li>Adagio Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/adgm-stock-quote/">ADGM</a>) shares are soaring close to 36% following its <a href="https://www.businesswire.com/news/home/20240731222906/en/Adagio-Medical-Announces-the-Closing-of-the-Business-Combination-with-ARYA-IV-Creating-a-Publicly-Traded-Company-Focused-on-the-Innovative-Technologies-for-Treatment-of-Cardiac-Arrhythmias">recent public debut</a>.</li>



<li>Akanda (NASDAQ:<a href="https://investorplace.com/stock-quotes/akan-stock-quote/">AKAN</a>) stock is surging over 35% alongside heavy pre-market trading.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) shares are gaining more than 29% on a <a href="https://www.businesswire.com/news/home/20240801299565/en/Exicure-Inc.-Receives-Positive-Listing-Determination-from-Nasdaq">positive listing update</a> from the Nasdaq Capital Market.</li>



<li>Australian Oilseeds (NASDAQ:<a href="https://investorplace.com/stock-quotes/coot-stock-quote/">COOT</a>) stock is rising 25% after announcing a <a href="https://www.nasdaq.com/press-release/australian-oilseeds-announces-appointment-new-independent-auditor-2024-08-01">new independent auditor</a>.</li>



<li>Tandem Diabetes Care (NASDAQ:<a href="https://investorplace.com/stock-quotes/tndm-stock-quote/">TNDM</a>) shares are increasing nearly 25% with the release of its <a href="https://www.nasdaq.com/press-release/tandem-diabetes-care-announces-second-quarter-2024-financial-results-and-increases">Q2 earnings report</a>.</li>



<li>Vaccinex (NASDAQ:<a href="https://investorplace.com/stock-quotes/vcnx-stock-quote/">VCNX</a>) stock is heading over 23% higher with <a href="https://www.nasdaq.com/press-release/vaccinex-reports-positive-data-signal-ad-phase-1b-2-trial-pepinemab-alzheimers">recent clinical trial news</a>.</li>



<li>AGBA Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/agba-stock-quote/">AGBA</a>) shares are climbing more than 13% without any clear news this morning.</li>



<li>Venus Concept (NASDAQ:<a href="https://investorplace.com/stock-quotes/vero-stock-quote/">VERO</a>) stock is jumping over 13% on Friday morning.</li>



<li>Integral Ad Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/ias-stock-quote/">IAS</a>) shares are up 13% with its <a href="https://www.nasdaq.com/press-release/ias-reports-second-quarter-2024-financial-results-2024-08-01">latest earnings news</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Gamer Pakistan (NASDAQ:<a href="https://investorplace.com/stock-quotes/gpak-stock-quote/">GPAK</a>) stock is plummeting almost 47% <a href="https://www.pr.com/press-release/917157#:~:text=(Nasdaq%3AGPAK)%20(GPAK,and%20that%20trading%20of%20the">alongside a delisting notice</a>.</li>



<li>Fresh Vine Wine (NYSEMKT:<a href="https://investorplace.com/stock-quotes/vine-stock-quote/">VINE</a>) shares are diving more than 37% with the <a href="https://www.nasdaq.com/press-release/fresh-vine-wine-inc-and-notes-live-inc-mutually-agree-terminate-merger-agreement-2024">termination of a merger agreement</a>.</li>



<li>Conn&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/">CONN</a>) stock is tumbling over 30% as Badcock Home Furniture &amp; More <a href="https://nypost.com/2024/08/01/business/major-furniture-chain-badcock-to-shut-all-its-stores-after-120-years/">shuts down all of its stores</a>.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) shares are taking a more than 24% beating on plans for a <a href="https://www.stocktitan.net/news/GNLN/greenlane-announces-board-s-approval-of-reverse-stock-split-9yehmvs5r4ed.html">reverse stock split</a>.</li>



<li>Procore Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/pcor-stock-quote/">PCOR</a>) stock is dropping 22% alongside its <a href="https://www.nasdaq.com/press-release/procore-announces-second-quarter-2024-financial-results-2024-08-01">Q2 earnings report</a>.</li>



<li>Estrella Immunopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/esla-stock-quote/">ESLA</a>) shares are sliding close to 21% on Friday morning.</li>



<li>Intel (NASDAQ:<a href="https://investorplace.com/stock-quotes/intc-stock-quote/">INTC</a>) stock is falling over 20% after releasing its <a href="https://www.theverge.com/2024/8/1/24210656/intel-is-laying-off-over-10000-employees-and-will-cut-10-billion-in-costs">Q2 earnings report</a>.</li>



<li>Smith Micro Software (NASDAQ:<a href="https://investorplace.com/stock-quotes/smsi-stock-quote/">SMSI</a>) shares are decreasing more than 19% with its <a href="https://seekingalpha.com/article/4709513-smith-micro-software-inc-smsi-q2-2024-earnings-call-transcript">latest earnings report</a>.</li>



<li>GraniteShares 2x Long AMZN Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/amzz-stock-quote/">AMZZ</a>) stock is slipping over 17%.</li>



<li>Snap (NYSE:<a href="https://investorplace.com/stock-quotes/snap-stock-quote/">SNAP</a>) shares close out our pre-market stock movers down more than 17% <a href="https://www.cnbc.com/2024/08/01/snap-shares-plunge-over-20percent-af.html">on weak guidance</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-aug-2nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Akanda&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/akan-stock-quote/">AKAN</a>) stock is on the rise Friday alongside heavy pre-market trading of the cannabis company&rsquo;s shares this morning.



This has more than 6.8 million shares of AKAN stock changing hands as of this writing. That&rsquo;s well above the company&rsquo;s daily average trading volume of about 1.3 million shares. It&rsquo;s also higher than Akanda&rsquo;s <a href="https://finance.yahoo.com/quote/AKAN/key-statistics/">float of 760,620 units</a>.



This increase in trading volume on Friday comes without any clear news from Akanda. That includes no press releases or filings with the Securities and Exchange Commission (SEC). There also isn&rsquo;t any analyst coverage causing today&rsquo;s rally.



One thing that traders will keep in mind is AKAN being a penny stock. This comes from its prior closing price of only $1.45 and a market capitalization of just $2.779 million.



<h2>What That Means for AKAN Stock</h2>



Investors will want to be wary of AKAN alongside today&rsquo;s rally. With the lack of news and sudden surge in trading volume, it has some signs of a pump and dump. The alternative is speculative traders boost the shares higher.



No matter the case, it makes AKAN stock a risky investment right now. That means investors will want to be careful about taking a stake in the company.



AKAN stock is up 34.1% as of Friday morning.



Investors will learn more about the most recent stock market stories below!



We have all of the hottest stock market news traders need to know about on Friday! Among that is what&rsquo;s happening with VSee Health&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vsee-stock-quote/">VSEE</a>) stock up today, the biggest pre-market stock movers this morning and more. All of this info is ready to go at the links below!



<h2>More Stock Market News for Friday</h2>



<ul><li><a href="https://investorplace.com/2024/08/why-is-vsee-health-vsee-stock-up-172-today/">Why Is VSee Health (VSEE) Stock Up 172% Today?</a></li>



<li><a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-aug-2nd/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Friday</a></li>



<li><a href="https://investorplace.com/2024/08/smci-stock-super-micro-launches-new-nvidia-offering/">SMCI Stock: Super Micro Launches New Nvidia Offering</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/why-is-akanda-akan-stock-up-34-today/">Why Is Akanda (AKAN) Stock Up 34% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Akanda (AKAN) Stock Up 34% Today?

Akanda Corp (AKAN) has released an update. Akanda Corp., a global cannabis player, has successfully acquired a hemp cultivation license in Canada, ...

Akanda Corp. Expands Canadian Cannabis Footprint

Akanda announces pricing of underwritten public offering

Akanda Corp (AKAN) has released an update. Akanda Corp., a medical cannabis company, has announced a public offering of 1.5 million shares at $1.00...

Akanda Corp's New Public Offering Aims to Raise $1.5 Million

Akanda Corp (AKAN) has released an update. Akanda Corp., an Ontario-based corporation, has entered into an underwriting agreement with Univest Secu...

Comments

Akanda

Vendite allo scoperto

Akanda (NASDAQ:AKAN) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO